Abstract
HTA170 Including Decision-Analytic Benefit-Harm Evaluation in HTA - Different Age Ranges and Screening Intervals in Breast Cancer Screening in Germany
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have